Equity Details
Price & Market Data
Price: $3.77
Daily Change: +$0.09 / 2.39%
Daily Range: $3.68 - $3.90
Market Cap: $229,600,896
Daily Volume: 571,581
Performance Metrics
1 Week: -8.96%
1 Month: -3.74%
3 Months: 13.86%
6 Months: -5.39%
1 Year: 23.32%
YTD: -2.77%
About Voyager Therapeutics, Inc. (VYGR)
Discover the financial pulse of Voyager Therapeutics, Inc. (VYGR). Current price: 3.77, daily change: +$0.09 / 2.39%. Market cap: 229,600,896. Get YTD and 52-week performance.
Company Details
Employees: 141
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
